Search results for "survival analysi"

showing 10 items of 752 documents

Familial adenomatosis polyposis-related desmoid tumours treated with low-dose chemotherapy: Results from an international, multi-institutional, retro…

2019

[Introduction] Desmoid tumour (DT) is a locally aggressive fibroblastic proliferative disease representing the most common extraintestinal manifestation of familial adenomatosis polyposis (FAP). As data on the activity of chemotherapy in these patients are limited, we examined the outcomes of patients treated with low-dose methotrexate (MTX)+vinca alkaloids (vinorelbine or vinblastine).

Adultfamilial adenomatosis polyposiCancer Researchmedicine.medical_specialtyVincaAdolescentVinca alkaloidsdesmoidmedicine.medical_treatmentPopulationVinorelbinechemotherapyGastroenterologymethotrexatevinca alkaloidsYoung Adultchemotherapy; desmoid; familial adenomatosis polyposis; methotrexate; vinca alkaloidsLow-dose chemotherapyInternal medicinemedicineHumansChemotherapyChildeducationDesmoidSurvival analysisRetrospective StudiesChemotherapyeducation.field_of_studybiologybusiness.industryFamilial adenomatosis polyposisbiology.organism_classificationmedicine.diseasefamilial adenomatosis polyposisMethotrexateAdenomatous Polyposis ColiOncologyFemaleSarcomabusinessProgressive diseasemedicine.drug
researchProduct

External validation of a prognostic model estimating the survival of patients with recurrent high-grade gliomas after reirradiation

2015

PURPOSE: We aimed to validate a controversial prognostic model for the survival of relapsed malignant glioma patients after reirradiation with an independent, multicentric patient cohort.METHODS AND MATERIALS: A total of 165 malignant glioma patients underwent reirradiation at 4 different institutions between 1994 and 2012. Twenty-two patients had a good (score 1), 44 had a moderate (score 2), and 99 had a poor prognosis (score 3 or 4). Four statistical methods were used to validate the prognostic model: First, we compared survival according to prognostic group in the construction and the validation cohort by visual comparison of the respective Kaplan-Meier plots. Second, discrimination was…

Adultmedicine.medical_specialtyAdolescentKaplan-Meier Estimate030218 nuclear medicine & medical imagingRe-IrradiationCohort Studies03 medical and health sciencesYoung Adult0302 clinical medicineTheoreticalModelsGliomamedicineHumansRadiology Nuclear Medicine and imagingTime pointChildSurvival rateSurvival analysisAgedKaplan-Meier Estimatebusiness.industryBrain NeoplasmsHazard ratioGliomaModels TheoreticalMiddle Agedmedicine.diseasePrognosisSurgerySurvival RateOncology030220 oncology & carcinogenesisCohortCalibrationRadiologybusinessCohort studyPractical radiation oncology
researchProduct

Survival of cervical cancer patients in Germany in the early 21st century: A period analysis by age, histology, and stage

2012

Background: Population-based studies on endometrial cancer providing survival estimates by age, histology, and stage have been sparse. We aimed to derive most up-to-date and detailed survival estimates for endometrial cancer patients in Germany. Methods: We used a pooled German national dataset including data from 11 cancer registries covering a population of 33 million people. 30,906 patients diagnosed with endometrial cancer in 1997-2006 were included. Period analysis was performed to calculate 5-year relative survival (RS) in 2002-2006. Trends in survival between 2002 and 2006 were examined using model-based period analysis. Age-adjustment was performed using five age groups (15-44, 45-5…

Adultmedicine.medical_specialtyAdolescentPopulationUterine Cervical NeoplasmsAge DistributionGermanyInternal medicinemedicineHumansRadiology Nuclear Medicine and imagingRegistriesStage (cooking)educationSurvival analysisAgedNeoplasm StagingCervical cancereducation.field_of_studyRelative survivalbusiness.industryEndometrial cancerAge FactorsCancerHematologyGeneral MedicineMiddle AgedPrognosismedicine.diseaseSurvival AnalysisSurgerySurvival RateOncologyFemaleSarcomabusinessActa Oncologica
researchProduct

Effects of anemia correction with epoetin beta in patients receiving radiochemotherapy for advanced cervical cancer

2007

Patients with cervical cancer frequently suffer from anemia. This two-stage, adaptive-design study investigated the effect of anemia correction with epoetin beta on treatment outcomes. Patients with stage IIB–IVA cervical cancer received radiochemotherapy (RCT) and were randomized to epoetin 150 IU/kg three times weekly (n = 34) or standard care (control; n = 40) for up to 12 weeks. Primary end point for stage 1 aimed to establish a correlation between anemia correction and treatment failure (no complete response or relapsing within 6 months after RCT initiation) as a proof of concept before moving into stage 2. Secondary end points included progression/relapse-free survival, overall surviv…

Adultmedicine.medical_specialtyAnemiaInjections Subcutaneousmedicine.medical_treatmentUterine Cervical NeoplasmsRisk AssessmentGastroenterologyDrug Administration Schedulelaw.inventionRandomized controlled trialReference ValueslawInternal medicinemedicineClinical endpointHumansAdverse effectErythropoietinSurvival analysisNeoplasm StagingProbabilityCervical cancerChemotherapyEpoetin betaDose-Response Relationship Drugbusiness.industryObstetrics and GynecologyAnemiaMiddle Agedmedicine.diseaseCombined Modality TherapyImmunohistochemistrySurvival AnalysisRecombinant ProteinsSurgeryLogistic ModelsTreatment OutcomeOncologyChemotherapy AdjuvantFemaleRadiotherapy AdjuvantbusinessFollow-Up StudiesInternational Journal of Gynecologic Cancer
researchProduct

About invasive cervical cancer: a French population based study between 1998 and 2010

2015

Abstract Objectives The new French cancer plan provides the implementation of organized screening. To make an assessment of the situation, we aim to describe clinical, tumor and survival characteristics of patients with invasive cervical cancer. Study design Data on women suffering from invasive cervical cancer and diagnosed from 1998 to 2010 were provided by the Cote d’Or breast cancer registry. Survival was described using the Kaplan–Meier method and prognostic factors of survival were estimated in a Cox proportional hazard model. Results On the whole, 1019 cancers have been collected including 311 (30.5%) invasive ones. The peak incidence was between 40 and 49 years, with an average age …

Adultmedicine.medical_specialtyDelayed DiagnosisPopulationUterine Cervical NeoplasmsCervix UteriBreast cancerInternal medicineEpidemiology of cancerHumansMedicineNeoplasm InvasivenessRegistrieseducationSurvival rateEarly Detection of CancerAgedNeoplasm StagingRetrospective StudiesCervical cancerGynecologyeducation.field_of_studybusiness.industryProportional hazards modelIncidenceIncidence (epidemiology)Obstetrics and GynecologyCancerMiddle AgedPrognosismedicine.diseaseSurvival AnalysisReproductive MedicineCarcinoma Squamous CellPatient ComplianceFemaleFrancebusinessFollow-Up StudiesEuropean Journal of Obstetrics & Gynecology and Reproductive Biology
researchProduct

Maternal caesarean section infection (MACSI) in Sierra Leone: a case-control study.

2020

Sierra Leone is the country with highest maternal mortality and infections are the underlying cause in 11% of maternal deaths, but the real burden remains unknown. This study aims to determine the incidence and risk factors of surgical site infection (SSI) post-caesarean section (CS) in women admitted to Princess Christian Maternity Hospital (PCMH) in Freetown, Sierra Leone. A prospective case-control (1:3 ratio) study was implemented from 1 May 2018 to 30 April 2019 and 11 women presenting with suspected or confirmed infection post-CS were screened for inclusion as a case. For each case, three patients undergoing CS on the same day and admitted to the same ward, but not presenting with SSI…

Adultmedicine.medical_specialtyEpidemiologymedicine.medical_treatmentSierra leoneSierra Leone03 medical and health sciences0302 clinical medicinePregnancyRisk FactorsmedicineHumansSurgical Wound InfectionCaesarean section030212 general & internal medicineProspective StudiesOriginal Paper030219 obstetrics & reproductive medicineObstetricsbusiness.industryCesarean SectionIncidence (epidemiology)IncidenceCase-control studyAntibioticOdds ratiosurgical site infectionmedicine.diseaseSurvival AnalysisConfidence intervalHospitalsInfectious Diseasesmaternal deathCase-Control StudiesMaternal deathFemalebusinessSurgical site infectionEpidemiology and infection
researchProduct

Morbidity after pelvic exenteration for gynecological malignancies: a retrospective multicentric study of 230 patients.

2013

ObjectiveOur study purpose was to evaluate morbidity and postoperative mortality in patients who underwent pelvic exenteration (PE) for primary or recurrent gynecological malignancies.MethodsWe identified 230 patients who underwent PE, referred to the gynecological oncology units of 4 institutions: Charitè University in Berlin, Friedrich-Schiller University in Jena, S. Orsola-Malpighi University in Bologna, and Catholic University in Rome and in Campobasso.ResultsThe median age was 55 years. The tumor site was the cervix in 177 patients, the endometrium in 28 patients, the vulva in 16 patients, and the vagina in 9 patients. Sixty-eight anterior, 31 posterior, and 131 total PEs were performe…

Adultmedicine.medical_specialtyGenital Neoplasms Femalemedicine.medical_treatmentYoung AdultRetrospective StudieGermanymedicineHumansPostoperative PeriodMortalityAgedRetrospective StudiesAged 80 and overCervical cancerVaginal cancerHysterectomyGynecological malignanciePelvic exenterationbusiness.industryEndometrial cancerMortality rateGynecological malignanciesObstetrics and GynecologyPerioperativeMiddle AgedVulvar cancermedicine.diseaseSurvival AnalysisPelvic ExenterationSurgerySettore MED/40 - GINECOLOGIA E OSTETRICIAItalyOncologyFemaleSurvival AnalysiMorbidityMorbidity pelvic exenteration gynecological malignanciesbusinessHuman
researchProduct

Surgical therapy of recurrent vulvar cancer.

2005

Objective The success of various surgical interventions in 201 cases with recurrent vulvar carcinoma was examined in the light of patients' pretreatment, surgical therapy, plastic reconstruction, and postoperative disease course. Study design A databank of standardized clinical data was analyzed using statistical procedures. Results Therapy was selected on an individual basis according to tumor status. Recurrence at a site distant from the primary tumor, particularly in the inguinal region, indicated a markedly unfavorable prognosis. In contrast, tumors recurring locally did not exhibit any significant differences. Plastic surgery reconstruction led to improvements with respect to operabili…

Adultmedicine.medical_specialtyReconstructive surgeryDatabases FactualVulvaTumor StatusGynecologic Surgical ProceduresmedicineHumansVulvar DiseasesAgedRecurrent Vulvar CarcinomaVulvar neoplasmAged 80 and overWound HealingVulvar Neoplasmsbusiness.industryCarcinomaObstetrics and GynecologyMiddle AgedPlastic Surgery Proceduresmedicine.diseasePrognosisPrimary tumorSurvival AnalysisSurgeryPlastic surgerymedicine.anatomical_structureFemaleNeoplasm Recurrence LocalbusinessAmerican journal of obstetrics and gynecology
researchProduct

Reconstructive plastic surgery in the treatment of vulvar carcinomas

2005

Abstract Objective The results obtained using plastic surgery reconstruction in 207 patients with a primary or recurrent vulvar carcinoma were analyzed with regard to the surgical procedures applied, pre-treatment and post-operative findings, along with the long-term oncological disease course. Study design Standardized data concerning the surgical procedures applied and clinical factors were collected in a databank and statistically analyzed. Results The flaps employed were termed either ‘local' (cutaneous or fasciocutaneous; n =84) or ‘regional' (myocutaneous, n =123). For local flaps, the rate of secondary healing was 31%, dropping to 20% for regional flaps. Such healing disturbances oft…

Adultmedicine.medical_specialtyThighSurgical FlapsDisease courseGynecologic Surgical ProceduresmedicineHumansSecondary healingAgedAged 80 and overRecurrent Vulvar CarcinomaWound HealingVulvar Neoplasmsbusiness.industryAdvanced stageObstetrics and GynecologyMiddle AgedPlastic Surgery Proceduresmedicine.diseaseSurvival AnalysisSurgeryPlastic surgeryStenosisTreatment Outcomemedicine.anatomical_structureReproductive MedicineFemaleVulvar CarcinomaNeoplasm Recurrence LocalbusinessEuropean Journal of Obstetrics & Gynecology and Reproductive Biology
researchProduct

Prospective randomized comparison of conventional instruments and the Harmonic Focus(®) device in breast-conserving therapy for primary breast cancer.

2011

Abstract Background In recent years, surgeons have utilized Harmonic instruments to perform breast cancer resection. Retrospective and prospective studies have demonstrated that the use of this surgical device for mastectomy and axillary dissection can reduce perioperative blood loss, seroma formation, and duration and total amount of drainage. No study has analyzed the feasibility of Harmonic instruments in breast-conserving surgery. We conducted a prospective, randomized clinical trial comparing Harmonic instrument and conventional surgery in the performance of breast-conserving surgery and axillary procedures to determine differences in surgical procedures, postoperative outcome, and com…

Adultmedicine.medical_specialtymedicine.medical_treatmentUltrasonic TherapyBreast NeoplasmsMastectomy SegmentalRisk AssessmentStatistics Nonparametriclaw.inventionBreast cancerPostoperative ComplicationsRandomized controlled triallawGermanymedicineBreast-conserving surgeryHumansNeoplasm InvasivenessProspective StudiesProspective cohort studyAgedNeoplasm StagingPostoperative CareAcademic Medical CentersChi-Square Distributionbusiness.industryGeneral MedicineMiddle Agedmedicine.diseaseSurgical InstrumentsSurvival AnalysisSurgeryLogistic ModelsSeromaTreatment OutcomeOncologySeromaMultivariate AnalysisSurgeryFemaleNeoplasm Recurrence LocalComplicationbusinessChi-squared distributionMastectomyFollow-Up StudiesEuropean journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
researchProduct